ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2667 • 2012 ACR/ARHP Annual Meeting

    Activated Memory B Cell Compartment in Rheumatoid Arthritis: Impact of B Cell Depletion Therapy

    Diana G. Adlowitz1, Jennifer Hossler1, Jamie Biear2, Christopher A. Cistrone1, Teresa Owen1, Wensheng Wang1, Arumugam Palanichamy1, Ignacio Sanz3 and Jennifer H. Anolik1, 1Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 3Allergy, Immunology and Rheumatology, Emory University School of Medicine, Atlanta, GA

    Background/Purpose: B cells are critical players in the orchestration of properly regulated immune responses.  This is achieved through the finely regulated participation of multiple B…
  • Abstract Number: 2668 • 2012 ACR/ARHP Annual Meeting

    Interferon and B-Cell Gene Signatures Contribute to Diagnosis of  pre-Clinical Rheumatoid Arthritis

    Joyce Lubbers1, Lotte A. van de Stadt2, Saskia Vosslamber1, John G. Wesseling1, Dirkjan van Schaardenburg2 and Cornelis L. Verweij3, 1Pathology, VU University Medical Center, Amsterdam, Netherlands, 2Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 3Pathology and Rheumatology, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Diagnosis of the preclinical phase of rheumatoid arthritis (pre-RA) allows timely start of treatment with the potential to prevent disease progression. It is known…
  • Abstract Number: 2669 • 2012 ACR/ARHP Annual Meeting

    TLR7 Ligation Contributes to Monocyte Migration in Rheumatoid Arthritis

    Nathan D. Chamberlain1, Seung-jae Kim1, Michael Volin2, William Swedler3, Suncica Volkov1 and Shiva Shahrara1, 1Medicine/Rheumatology, University of Illinois at Chicago, Chicago, IL, 2Department of Microbiology and Immunology, Chicago College of Osteopathic Medicine Midwestern University, Downers Grove, IL, 3Section of Rheumatology, University of Illinois at Chicago, Chicago, IL

    Background/Purpose: The aim of the study was to characterize the expression of TLR7 in rheumatoid arthritis (RA) peripheral blood (PB) cells and to examine the…
  • Abstract Number: 2671 • 2012 ACR/ARHP Annual Meeting

    A Genome-Wide Association Study Establishes Muliple Susceptibility Loci for Sjögren’s Syndrome

    Christopher J. Lessard1, He Li2, Indra Adrianto3, John A. Ice3, Roland Jonsson4, Gabor G. Illei5, Maureen Rischmueller6, Gunnel Nordmark7, Xavier Mariette8, Corinne Miceli-Richard9, Marie Wahren-Herlenius10, Torsten Witte11, Michael T. Brennan12, Roald Omdal13, Patrick M. Gaffney3, James A. Lessard14, Wan-Fai Ng15, Nelson L. Rhodus16, Barbara M. Segal17, R. Hal Scofield18, Judith A. James19, Juan-Manuel Anaya20, John B. Harley21, Courtney G. Montgomery3 and Kathy Moser Sivils19, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation; University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma CIty, OK, 3Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Broegelmann Research Laboratory, the Gade Institute, University of Bergen, Bergen, Norway, 5Sjogren's Clinic, NIDCR/ NIH, Bethesda, MD, 6Rheumatology Department, Queen Elizabeth Hospital, Adelaide, Australia, 7Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 8Rheumatology, Université Paris-Sud, Le Kremlin Bicetre, France, 9Hopital Bicêtre, Le Kremlin Bicêtre, France, 10Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 11Clinical Immunology and Rheumatology, Medical University Hannover, Hanover, Germany, 12Nidcr NIH, Carolinas Medical Center, Charlotte, NC, 13Department of Internal Medicine, Stavanger university Hospital, Stavanger, Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, 14Valley Bone and Joint Clinic, Grand Forks, ND, 15Musculoskeletal Research Group Institute of Cellular Medicine, Newcastle University, Newcastle University, Newcastle, England, 16University of Minnesota, Minneapolis, MN, 17Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 18Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 19Oklahoma Medical Research Foundation, Oklahoma City, OK, 20School of Medicine and Health Sciences, Universidad del Rosario. Center for Autoimmune Diseases Research (CREA), Bogotá, Colombia, 21Division of Rheumatology and The Center for Autoimmune Genomics & Etiology, University of Cincinnati, Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs Medical Center, Cincinnati, OH

    Background/Purpose: Sjögren’s syndrome (SS) is a common, clinically heterogeneous autoimmune disease characterized by exocrine gland dysfunction that involves both innate and adaptive immune responses. A…
  • Abstract Number: 2672 • 2012 ACR/ARHP Annual Meeting

    Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren’s Syndrome (SS) According to Specific Subphenotypes and Ancestry

    Lindsey A. Criswell1, Kimberly E. Taylor2, Caitlin McHugh3, Cathy Laurie3, Kimberly Doheny4, Mi Y. Lam2, Joanne Nititham5, Laura Bierut6, Emily L. Harris7, Alan N. Baer8, Stephen Challacombe9, Yi Dong10, Hector Lanfranchi11, Morten Schiodt12, M. Srinivasan13, Susumu Sugai14, Hisanori Umehara15, Frederick B. Vivino16, Zhao Yan17, Stephen Shiboski2, Troy Daniels18, John S. Greenspan19, Caroline Shiboski19 and SICCA20, 1Rosalind Russell Medical Research Center for Arthritis, Department of Medicine, Division of Rheumatology, University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3University of Washington, Biostatistics, Seattle, WA, 4Center for Inherited Disease Research, Baltimore, MD, 5Medicine, Rosalind Russell Medical Research Center for Arthritis, San Francisco, CA, 6Psychiatry, Washington University, St. Louis, MO, 7National Institute of Dental and Craniofacial Research, Bethesda, MD, 8Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 9Kings College London, London, United Kingdom, 10Dept of Rheumatology, Peking Univ Med Coll Hospital, East City Beijing, China, 11University of Buenos Aires, Buenos Aires, Argentina, 12Righospitalet, Copenhagen, Denmark, 13Aravind Eye Hospital, Madurai, India, 14Kanazawa Medical University, Ishikawa, Japan, 15Internal Medicine, Division of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan, 16Medicine, Penn Presbyt Med Ctr, Philadelphia, PA, 17Department of Rheumatology, Peking Union Medical College Hospital, Beijing, China, 18Orofacial Sciences, Box 0422, UCSF Schools of Medicine & Dentistry, San Francisco, CA, 19Orofacial Sciences, University of California, San Francisco, San Francisco, CA, 20San Francisco, CA

    Background/Purpose: Our goal is to define the contribution of genetic factors to SS and related subphenotypes. Methods: We studied 2,459 participants in the Sjögren’s International…
  • Abstract Number: 2673 • 2012 ACR/ARHP Annual Meeting

    Sibling Relative Risk and Heritability of Sjögren’s Syndrome: A Nationwide Population Study in Taiwan

    Chang-Fu Kuo1, Matthew J. Grainge2, Kuang-Hui Yu3, Lai-Chu See4, Shue-Fen Luo3, Ana M. Valdes5, I-Jun Chou6, Hsiao-Chun Chang3, Weiya Zhang1 and Michael Doherty7, 1Academic Rheumatology, School of Clinical Sciences, University of Nottingham, Nottingham, United Kingdom, 2Division of Epidemiology and Public Health, School of Community Health Sciences, University of Nottingham, Nottingham, United Kingdom, 3Division of Rheumatology, Immunology and Allergy, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 4Department of Public Health, College of Medicine, Chang Gung University, Taoyuan, Taiwan, 5Dept of Twin Research and Genetic Epidemiology, St. Thomas' Hospital, King's College London, Dept of Twin Research and Genetic Epidemiology, St. Thomas' Hospital, King's College London, London, United Kingdom, 6Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 7Academic Rheumatology, University of Nottingham, Nottingham, United Kingdom

    Background/Purpose: Although familial aggregation has been found in many autoimmune diseases, the evidence for familial aggregation in Sjögren’s syndrome is lacking. The aims of this…
  • Abstract Number: 2674 • 2012 ACR/ARHP Annual Meeting

    Cis-Expression Quantitative Trait Loci Analysis of Dysregulated Interferon-Pathway Genes Identifies HLA-C and OAS1 As Novel Candidates for Susceptibility to Sjögren’s Syndrome

    He Li1, John A. Ice2, Jennifer A. Kelly3, Indra Adrianto2, Stuart B. Glenn4, Kimberly S. Hefner5, Evan G. Vista6, Donald U. Stone7, Raj Gopalakrishnan8, Glen D. Houston9, David M. Lewis10, Michael Rohrer8, Pamela Hughes8, John B. Harley11, Courtney G. Montgomery2, James Chodosh7, James A. Lessard12, Juan-Manuel Anaya13, Barbara M. Segal14, Nelson L. Rhodus15, Lida Radfar16, Mark B. Frank17, R. Hal Scofield18, Christopher J. Lessard19 and Kathy Moser Sivils3, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Hefner Eye Care and Optical Center, Oklahoma City, OK, 6Rheumatology and Clinical Immunology, University of Santo Tomas, Taguig City, Philippines, 7Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 8Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, 9Collage of Denistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 10College of Dentistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 11Division of Rheumatology and The Center for Autoimmune Genomics & Etiology, University of Cincinnati, Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs Medical Center, Cincinnati, OH, 12Valley Bone and Joint Clinic, Grand Forks, ND, 13School of Medicine and Health Sciences, Universidad del Rosario. Center for Autoimmune Diseases Research (CREA), Bogotá, Colombia, 14Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 15University of Minnesota, Minneapolis, MN, 16University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Arthritis & Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 18Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 19Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation; University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a progressive autoimmune exocrinopathy characterized by symptoms of dry eyes and mouth present in 0.7-1% of Europeans. Dysregulation of interferon…
  • Abstract Number: 2675 • 2012 ACR/ARHP Annual Meeting

    Oral and Gut Microbiota Influence Immune Responses to Sjogren’s Syndrome Associated Antigen Ro60

    Agnieszka Szymula1, Barbara Szczerba1, Harini Bagavant1, Shu-Man Fu2 and Umesh Deshmukh3, 1Department of Medicine, University of Virginia, Charlottesville, VA, 2University of Virginia, Charlottesville, VA, 3Medicine, University of Virginia, Charlottesville, VA

    Background/Purpose: Autoantibodies reactive against Ro60 protein are often found in patients with Sjogren’s syndrome.  This study was undertaken to investigate the role of oral and…
  • Abstract Number: 2676 • 2012 ACR/ARHP Annual Meeting

    Long-Term Humoral Autoimmunity to Ro60 in Primary Sjögren’s Syndrome Is Driven by Clonal Succession

    Rhianna Lindop1, Isabell Bastian1, Georgia Arentz1, Lauren Thurgood1, Andrew Whyte1, Tim, K. Chataway2, Michael Jackson1 and Tom Gordon1, 1Immunology, Flinders Medical Centre and Flinders University, Adelaide, Australia, 2Human Physiology, School of Medicine, Flinders University, Adelaide, Australia

    Background/Purpose : Long-lived humoral autoimmunity to Ro60 is considered a hallmark of primary Sjögren’s syndrome (SS), but the mechanism by which this immunity is sustained over…
  • Abstract Number: 2677 • 2012 ACR/ARHP Annual Meeting

    IL-23 Controls Autoimmunity by Facilitating Clearance of Apoptotic Bodies in the Marginal Zone in Lupus-Prone BXD2 Mice

    Hao Li1, Hui-Chen Hsu2, Qi Wu3, PingAr Yang3, Jun Li4, Daniel Cua5, Mohamed Oukka6 and John D. Mountz7, 1Microbiology, University of Alabama at Birmingham, Birmingham, AL, 2Department of Medicine, Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Med - Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5Discovery Research, Merck Research Laboratory, Palo Alto, CA, 6Pediatrics, Seattle, WA, 7Dept of Med/Rheumatology Div, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Failure to clear apoptotic bodies is a central pathogenic mechanism for SLE. We have observed that spontaneous systemic autoimmunity and lupus in BXD2 mice…
  • Abstract Number: 2678 • 2012 ACR/ARHP Annual Meeting

    Novel Nuclear Export Inhibitors Deplete Autoreactive Plasma Cells and Protect Mice with Lupus-Like Disease From Nephritis

    Teresa Owen1, Wensheng Wang1, Dilara McCauley2, Laura Strojny1, Jennifer Hossler1, Javier Rangel-Moreno3, Michael Kauffman2, Sharon Shacham4 and Jennifer H. Anolik5, 1Medicine- Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2Karyopharm, Therapeutics Inc., Natick, MA, 3Medicine- Allergy, Immunology, and Rheumatology, University of Rochester, Rochester, NY, 4Karyopharm Therapeutics Inc., Natick, MA, 5Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY

    Background/Purpose:  Most therapies currently used to treat systemic lupus erythematosus (SLE) and B cell targeted therapies under development do not effectively target plasma cells and…
  • Abstract Number: 2679 • 2012 ACR/ARHP Annual Meeting

    Loss of Caspase 8 in Dendritic Cells Induces a Systemic Lupus Erythematosus-Like Disease That Is Independent of the Necroptosome

    Carla M. Cuda1, Alexander V. Misharin2, Rana Saber2, G. Kenneth Haines III3, Jack Hutcheson4, Chandra Mohan5 and Harris R. Perlman6, 1Medicine / Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine/Rheumatology, Northwestern University, Chicago, IL, 3Department of Pathology, Yale University, New Haven, CT, 4Internal Medicine - Rheumatic Diseases, University of Texas Southwestern Medical Center, Dallas, TX, 5Internal Medicine/Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, 6Feinberg School of Medicine, Northwestern University, Chicago, IL

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multi-organ, destructive autoimmune disease characterized by pathogenic autoantibodies.  Though it is accepted that dendritic cells (DCs) play an…
  • Abstract Number: 2680 • 2012 ACR/ARHP Annual Meeting

    Soluble Receptor for Advanced Glycation End Products Alleviates Nephritis in NZB/WF1 Mice

    Sang-Won Lee1, Kyu-Hyoung Park1, Sungha Park2, Ji-Hye Kim1, Sung-You Hong2, Soo Kon Lee3, Donghoon Choi2 and Yong-Beom Park4, 1Internal Medicine, Yonse University College of Medicine, Seoul, South Korea, 2Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, 3Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

    Background/Purpose: The receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor that interacts with multiple ligands such as high mobility group box 1…
  • Abstract Number: 2681 • 2012 ACR/ARHP Annual Meeting

    Blocking the Serum Protease Inhibitor Activity of Plasminogen Activator Inhibitor-1 Protects Mice From Development of Glomerulonephritis in a Model of Lupus Nephritis

    Brian Naiman1, Tracy Delaney1, Lily Cheng2, Philip Brohawn2, Chris Morehouse2, Christopher Groves1, Isabelle de-Mendez3, Dominic Corkill4, Anthony Coyle5, Ronald Herbst1 and Jane Connor1, 1Respiration, Inflammation and Autoimmunity, MedImmune, LLC, Gaithersburg, MD, 2Translational Sciences, MedImmune, LLC, Gaithersburg, MD, 3Research, MedImmune, LLC, Cambridge, United Kingdom, 4Respiration, Inflammation and Autoimmunity, MedImmune, LLC, Cambridge, United Kingdom, 5Centers for Therapeutic Innovation, Pfizer, Inc. (formerly MedImmune LLC, Gaithersburg, MD, USA), Cambridge, MA

    Background/Purpose: Lupus nephritis is an autoimmune disorder which is characterized by extracellular matrix accumulation driven by immune complex deposition and in which thrombosis and sclerosis…
  • Abstract Number: 2682 • 2012 ACR/ARHP Annual Meeting

    Calcium/Calmodulin-Dependent Protein Kinase IV Suppresses IL-2 Production and Regulatory T Cell Activity in Systemic Lupus Erythematosus

    Tomohiro Koga1, Kunihiro Ichinose2, Masayuki Mizui3, José C. Crispín4 and George C. Tsokos4, 1Medicine/Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Department of Immunology and Rheumatology, Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 3Division of Rheumatology, Department of Medicine,, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 4Medicine/Rheumatology, BIDMC, Harvard Medical School, Boston, MA

    Background/Purpose: T cells from patients with SLE exhibit abnormal signaling upon TCR engagement and have an altered gene expression profile. Accordingly, the regulation of several transcription factors…
  • « Previous Page
  • 1
  • …
  • 2421
  • 2422
  • 2423
  • 2424
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology